Lv2
110 积分 2024-04-09 加入
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial
1天前
已完结
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial
1天前
已完结
OC-006: Concomitant treatment (CRT or cetuximab/RT) with or without induction TPF in Locally Advanced head and neck
1天前
已完结
Recent Advances in FLT3-Based Dual Inhibitors: A Promising Strategy for the Treatment of Acute Myeloid Leukemia
1个月前
已完结
Recent progress of JAK inhibitors for hematological disorders
1个月前
已关闭
Recommendations for the Use of White Blood Cell Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
1个月前
已完结
A Review of Micronutrients and the Immune System–Working in Harmony to Reduce the Risk of Infection
1个月前
已完结
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
1个月前
已完结
Control of Ph+ and additional chromosomal abnormalities in chronic myeloid leukemia by tyrosine kinase inhibitors
1个月前
已完结
Eltrombopag Combined with G-CSF and Cyclosporine Could Effect for Severe Acquired Aplastic Anemia
1个月前
已关闭
皖公网安备34019202002308
